- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06620445
Efficacy of Psychological Intervention for Children With Cancer
Efficacy of Psychological Intervention for Children With Cancer: A Randomized Controlled Trail
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background:
Children with cancer and their families experience various psychosocial challenges during and after treatment, including physical and cognitive changes due to medical treatment, alterations in social and familial roles, and the potential threat of death.
While most children and families cope and adjust well to the diagnosis and treatment of cancer, a subset of children is at increased risk for anxiety, depression, educational, and relationship difficulties. Caregivers and siblings of pediatric patients are also at risk for heightened distress and post-traumatic stress. Psychosocial care and interventions can play an important role in supporting the well-being of the entire family, beginning at diagnosis.
The psychological impact of cancer on Pakistani children is diverse and far-reaching, ranging from concerns about their future to worries about appearing different from their peers. Given the high prevalence of psychological difficulties among pediatric cancer patients in Pakistan, it is essential to determine the effectiveness of interventions offered to support their mental health and well-being. Studies on cancer patients related to their psychiatric problems are already rare in Pakistan.
Objective:
The main objective of this study is to compare the effect of psychological intervention, such as cognitive-behavioral therapy (CBT), to the routine care given among pediatric oncology patients. The findings of this study will provide evidence to support the integration of psychological intervention strategies into pediatric oncology practice, thus adding new knowledge to the literature and helping improve the care of children with malignancies receiving chemotherapy.
Study Design:
The study will be conducted at the Pediatric Oncology Unit, PIMS, Islamabad. This study will be a two-armed longitudinal, randomized control trial expected to run for six months. Children with malignancy receiving chemotherapy will be recruited and randomly assigned to experimental or control groups.
Intervention:
The experimental group will receive five sessions of cognitive-behavioral intervention, where maladaptive thoughts and behavior will be identified, behavioral activation will be encouraged, and deep breathing exercises will be practiced. The control group will receive the usual care.
Recruitment and Sample:
The recruitment process will involve the random selection of children diagnosed with malignancies and undergoing treatment at the Pediatric Oncology Unit, the Children's Hospital PIMS Islamabad, Pakistan.
Outcome Measures:
The outcomes will be measured at baseline, post-intervention, and one month after the intervention using the Revised Child Anxiety and Depression Scale and Pediatric Quality of Life Inventory Generic Core Score 4.0.
Data Analysis:
Data analysis will be conducted using SPSS version 23.
Ethical Considerations:
Permission to conduct the study will be acquired from the Ethical Review Board (ERB) of PIMS Islamabad.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Islamabad, Pakistan, 44000
- Muhammad Wasim Khan
-
Contact:
- Muhammad Wasim Khan, MBBS, FCPS
- Phone Number: 03334411620
- Email: mail4wasimkhan@gmail.com
-
Contact:
- Nuzhat Yasmeen, MBBS, FCPS, DPH, PhD
- Phone Number: 03332135791
- Email: drnuzhatyasmeen@yahoo.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Eligibility Criteria:
Inclusion Criteria:
- Children aged 16-18 years
- Diagnosed with malignancy
- Recieving chemotherapy at the Pediatric Oncology Department of PIMS Islamabad
- Able to understand and participate in CBT sessions
- Parent/Caregiver consent and child assent
Exlusion Criteria:
- Children with severe cognitive impairment or intellectual disability
- Children with a comorbid medical conditions
- Children whose parents or caregivers are unable to provide consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Interventional Group
The Intervention or CBT group included 40 children aged 8-16 years with malignancies recieving chemotherapy.
They will recieve weekly five sessions of CBT (30-35 minutes per session)
|
This RCT aims to evaluate the effect of Cognitive Behavioral Therapy (CBT) compared to usual care (UC) in pediatric oncology patients.
We hypothesize that those receiving CBT will report lower depression and anxiety and improved QoL six months post-enrollment.
Other Names:
|
|
No Intervention: Control or Usual Care Group
The Control or No Intervention Group also known as Comparision Group or Usual Group will recieve the standard care or usual care for their condition.
It will serve as a baseline for the CBT or Intervention Group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Revised Child Anxiety and Depression Scale (RCADS)
Time Frame: Baseline (before the intervention) and one month post intervention (after the five weekly sessions of CBT)
|
The RCADS is a standardized, self reported scale measuring anxiety and depression symptoms among children aged 8-18 years.
|
Baseline (before the intervention) and one month post intervention (after the five weekly sessions of CBT)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pediatric QoL
Time Frame: Baseline and one month post intervention
|
It evaluates physical, emotional, social and school funtioning.
|
Baseline and one month post intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- F.1-1/2015/ERBSZABMU/1311
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
Clinical Trials on Interventiion or CBT Group
-
Bogazici UniversityRecruitingAnxietyTurkey (Türkiye)
-
University of California, San FranciscoCompletedDepressionUnited States
-
Mersin UniversityCompletedMental Health IssueTurkey
-
Florida International UniversityNational Institute of Mental Health (NIMH)CompletedAnxiety DisordersUnited States
-
New York Institute of TechnologyCompleted
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)RecruitingClinical High Risk for Psychosis (CHR)United States
-
University of AlbertaAlberta Health servicesTerminated
-
University of MinnesotaNational Institute of Mental Health (NIMH)Completed
-
University of CopenhagenUniversity of Exeter; The University of Western AustraliaCompletedDepression | Recurrent DepressionDenmark
-
Johns Hopkins UniversityMigraine Research FoundationCompletedAnxiety | Headache | PediatricUnited States